Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.585 USD | +2.26% | +0.32% | -33.68% |
May. 15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
May. 09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.68% | 64.25M | |
+46.31% | 56.65B | |
-6.46% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.80% | 26.75B | |
-21.26% | 19.03B | |
+0.92% | 12.28B | |
+24.43% | 12.26B | |
+27.23% | 12.04B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- JMP Securities Raises Rallybio's Price Target to $34 From $29, Maintains Market Outperform Rating